{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:18:29Z","timestamp":1793798309502,"version":"4.6.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T00:00:00Z","timestamp":1598745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-DA039192"],"award-info":[{"award-number":["R01-DA039192"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10067-020-05372-1","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T06:02:37Z","timestamp":1598767357000},"page":"1221-1231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6313-2738","authenticated-orcid":false,"given":"Akhil","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukaila A.","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,30]]},"reference":[{"issue":"7123","key":"5372_CR1","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/bmj.315.7123.1704","volume":"315","author":"A Boonen","year":"1997","unstructured":"Boonen A, van de Rest J, Dequeker J, van der Linden S (1997) How Renoir coped with rheumatoid arthritis. Bmj. 315(7123):1704\u20131708. https:\/\/doi.org\/10.1136\/bmj.315.7123.1704","journal-title":"Bmj."},{"issue":"3","key":"5372_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jbspin.2014.10.012","volume":"82","author":"C Lahaye","year":"2015","unstructured":"Lahaye C, Tatar Z, Dubost JJ, Soubrier M (2015) Overview of biologic treatments in the elderly. Jt Bone Spine 82(3):154\u2013160. https:\/\/doi.org\/10.1016\/j.jbspin.2014.10.012","journal-title":"Jt Bone Spine"},{"issue":"3","key":"5372_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cger.2014.04.001","volume":"30","author":"J Hugo","year":"2014","unstructured":"Hugo J, Ganguli M (2014) Dementia and cognitive impairment: epidemiology, diagnosis, and treatment clinics in geriatric medicine. Clin Geriatr Med 30(3):421\u2013442. https:\/\/doi.org\/10.1016\/j.cger.2014.04.001","journal-title":"Clin Geriatr Med"},{"issue":"8","key":"5372_CR4","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/acr.21683","volume":"64","author":"SY Shin","year":"2012","unstructured":"Shin SY, Katz P, Wallhagen M, Julian L (2012) Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res 64(8):1144\u20131150. https:\/\/doi.org\/10.1002\/acr.21683","journal-title":"Arthritis Care Res"},{"issue":"5","key":"5372_CR5","first-page":"856","volume":"36","author":"JH Lee","year":"2018","unstructured":"Lee JH, Kim GT, Kim YK, Lee SG (2018) Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes. Clin Exp Rheumatol 36(5):856\u2013861","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"5372_CR6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/acr.21691","volume":"64","author":"SG Murray","year":"2012","unstructured":"Murray SG, Yazdany J, Kaiser R, Criswell LA, Trupin L, Yelin EH, Katz PP, Julian LJ (2012) Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus. Arthritis Care Res 64(9):1328\u20131333. https:\/\/doi.org\/10.1002\/acr.21691","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5372_CR7","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","volume":"42","author":"JG Hanly","year":"1999","unstructured":"Hanly JG, Hong C, Smith S, Fisk JD (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42(4):728\u2013734. https:\/\/doi.org\/10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5372_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41927-018-0014-y","volume":"2","author":"A Jagpal","year":"2018","unstructured":"Jagpal A, Navarro-Mill\u00e1n I (2018) Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment. BMC Rheumatol 2(1):10. https:\/\/doi.org\/10.1186\/s41927-018-0014-y","journal-title":"BMC Rheumatol"},{"issue":"3","key":"5372_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/art.20878","volume":"52","author":"H Maradit-Kremers","year":"2005","unstructured":"Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722\u2013732. https:\/\/doi.org\/10.1002\/art.20878","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5372_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/kes243","volume":"52","author":"KP Liao","year":"2013","unstructured":"Liao KP, Solomon DH (2013) Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford, England) 52(1):45\u201352. https:\/\/doi.org\/10.1093\/rheumatology\/kes243","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"5372_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/rheumatology\/keu376","volume":"54","author":"CH Im","year":"2014","unstructured":"Im CH, Kim NR, Kang JW, Kim JH, Kang JY, Bae GB, Nam EJ, Kang YM (2014) Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis. Rheumatology. 54(5):808\u2013815. https:\/\/doi.org\/10.1093\/rheumatology\/keu376","journal-title":"Rheumatology."},{"issue":"12","key":"5372_CR12","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3899\/jrheum.130365","volume":"40","author":"S Ajeganova","year":"2013","unstructured":"Ajeganova S, Andersson MLE, Frosteg\u00e5rd J, Hafstr\u00f6m I (2013) Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol 40(12):1958\u20131966. https:\/\/doi.org\/10.3899\/jrheum.130365","journal-title":"J Rheumatol"},{"issue":"7","key":"5372_CR13","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/art.11078","volume":"48","author":"I del Rinc\u00f3n","year":"2003","unstructured":"del Rinc\u00f3n I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A (2003) Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 48(7):1833\u20131840. https:\/\/doi.org\/10.1002\/art.11078","journal-title":"Arthritis Rheum"},{"issue":"25","key":"5372_CR14","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa035611","volume":"349","author":"Y Asanuma","year":"2003","unstructured":"Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MRF, Raggi P, Stein CM (2003) Premature coronary-artery atherosclerosis in systemic lupus Erythematosus. N Engl J Med 349(25):2407\u20132415. https:\/\/doi.org\/10.1056\/NEJMoa035611","journal-title":"N Engl J Med"},{"issue":"1","key":"5372_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","volume":"43","author":"SR Schoenfeld","year":"2013","unstructured":"Schoenfeld SR, Kasturi S, Costenbader KH (2013) The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 43(1):77\u201395. https:\/\/doi.org\/10.1016\/j.semarthrit.2012.12.002","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"5372_CR16","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","volume":"12","author":"I Hollan","year":"2013","unstructured":"Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12(10):1004\u20131015. https:\/\/doi.org\/10.1016\/j.autrev.2013.03.013","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5372_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3899\/jrheum.130874","volume":"41","author":"CM Bartels","year":"2014","unstructured":"Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, Greenlee RT (2014) Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol 41(4):680\u2013687. https:\/\/doi.org\/10.3899\/jrheum.130874","journal-title":"J Rheumatol"},{"issue":"1","key":"5372_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","volume":"15","author":"G-C Wu","year":"2016","unstructured":"Wu G-C, Liu H-R, Leng R-X, Li X-P, Li X-M, Pan H-F, Ye DQ (2016) Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev 15(1):22\u201337. https:\/\/doi.org\/10.1016\/j.autrev.2015.10.002","journal-title":"Autoimmun Rev"},{"issue":"12","key":"5372_CR19","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/acr.22914","volume":"68","author":"Y-R Lin","year":"2016","unstructured":"Lin Y-R, Chou L-C, Chen H-C, Liou T-H, Huang S-W, Lin H-W (2016) Increased risk of dementia in patients with systemic lupus erythematosus: a nationwide population-based cohort study. Arthritis Care Res 68(12):1774\u20131779. https:\/\/doi.org\/10.1002\/acr.22914","journal-title":"Arthritis Care Res"},{"issue":"8","key":"5372_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.23098","volume":"57","author":"P Tomietto","year":"2007","unstructured":"Tomietto P, Annese V, D'Agostini S, Venturini P, La Torre G, De Vita S et al (2007) General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Care Res 57(8):1461\u20131472. https:\/\/doi.org\/10.1002\/art.23098","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5372_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","volume":"42","author":"S Menon","year":"1999","unstructured":"Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA (1999) A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum 42(4):735\u2013741. https:\/\/doi.org\/10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","journal-title":"Arthritis Rheum"},{"issue":"5","key":"5372_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/jscd.2001.29818","volume":"10","author":"F Gonzales-Portillo","year":"2001","unstructured":"Gonzales-Portillo F, McIntyre JA, Wagenknecht DR, Williams LS, Bruno A, Biller J (2001) Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease. J Stroke Cerebrovasc Dis 10(5):222\u2013226. https:\/\/doi.org\/10.1053\/jscd.2001.29818","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"5372_CR23","doi-asserted-by":"publisher","first-page":"e0196487-e","DOI":"10.1371\/journal.pone.0196487","volume":"13","author":"A Duarte-Garc\u00eda","year":"2018","unstructured":"Duarte-Garc\u00eda A, Romero-D\u00edaz J, Ju\u00e1rez S, Cicero-Casarrubias A, Fragoso-Loyo H, N\u00fa\u00f1ez-Alvarez C et al (2018) Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with systemic lupus erythematosus and cognitive dysfunction. PLoS One 13(5):e0196487-e. https:\/\/doi.org\/10.1371\/journal.pone.0196487","journal-title":"PLoS One"},{"issue":"4","key":"5372_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3978\/j.issn.2305-5839.2015.02.05","volume":"3","author":"P Ungprasert","year":"2015","unstructured":"Ungprasert P, Srivali N, Kittanamongkolchai W (2015) Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Transl Med 3(4):51. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.02.05","journal-title":"Ann Transl Med"},{"key":"5372_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/OARRR.S206931","volume":"11","author":"R Peluso","year":"2019","unstructured":"Peluso R, Caso F, Tasso M, Sabbatino V, Lupoli R, Dario Di Minno MN et al (2019) Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis. Open Access Rheumatol 11:143\u2013156. https:\/\/doi.org\/10.2147\/OARRR.S206931","journal-title":"Open Access Rheumatol"},{"key":"5372_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer's Dement (New York, N Y) 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimer's Dement (New York, N Y)"},{"issue":"22","key":"5372_CR27","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","volume":"68","author":"ZS Tan","year":"2007","unstructured":"Tan ZS, Beiser AS, Vasan RS, Roubenoff R, Dinarello CA, Harris TB, Benjamin EJ, Au R, Kiel DP, Wolf PA, Seshadri S (2007) Inflammatory markers and the risk of Alzheimer disease. Neurology. 68(22):1902\u20131908. https:\/\/doi.org\/10.1212\/01.wnl.0000263217.36439.da","journal-title":"Neurology."},{"issue":"5","key":"5372_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s10067-018-3990-9","volume":"37","author":"LE Petersen","year":"2018","unstructured":"Petersen LE, Baptista TSA, Molina JK, Motta JG, do Prado A, Piovesan DM et al (2018) Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors. Clin Rheumatol 37(5):1171\u20131181. https:\/\/doi.org\/10.1007\/s10067-018-3990-9","journal-title":"Clin Rheumatol"},{"issue":"9","key":"5372_CR29","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s10067-017-3724-4","volume":"36","author":"TSA Baptista","year":"2017","unstructured":"Baptista TSA, Petersen LE, Molina JK, de Nardi T, Wieck A, do Prado A et al (2017) Autoantibodies against myelin sheath and S100\u03b2 are associated with cognitive dysfunction in patients with rheumatoid arthritis. Clin Rheumatol 36(9):1959\u20131968. https:\/\/doi.org\/10.1007\/s10067-017-3724-4","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5372_CR30","first-page":"25","volume":"8","author":"E Tobinick","year":"2006","unstructured":"Tobinick E, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. MedGenMed. 8(2):25","journal-title":"MedGenMed."},{"key":"5372_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-2094-5-2","volume":"5","author":"EL Tobinick","year":"2008","unstructured":"Tobinick EL, Gross H (2008a) Rapid cognitive improvement in Alzheimer\u2019s disease following perispinal etanercept administration. J Neuroinflammation 5:2. https:\/\/doi.org\/10.1186\/1742-2094-5-2","journal-title":"J Neuroinflammation"},{"key":"5372_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2377-8-27","volume":"8","author":"EL Tobinick","year":"2008","unstructured":"Tobinick EL, Gross H (2008b) Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer\u2019s disease. BMC Neurol 8:27. https:\/\/doi.org\/10.1186\/1471-2377-8-27","journal-title":"BMC Neurol"},{"issue":"21","key":"5372_CR33","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1212\/wnl.0000000000001617","volume":"84","author":"J Butchart","year":"2015","unstructured":"Butchart J, Brook L, Hopkins V, Teeling J, P\u00fcntener U, Culliford D et al (2015) Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial. Neurology. 84(21):2161\u20132168. https:\/\/doi.org\/10.1212\/wnl.0000000000001617","journal-title":"Neurology."},{"issue":"2","key":"5372_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/1756-185x.13246","volume":"21","author":"K-T Chen","year":"2018","unstructured":"Chen K-T, Chen Y-C, Fan Y-H, Lin W-X, Lin W-C, Wang Y-H, Lin L, Chiou JY, Wei JCC (2018) Rheumatic diseases are associated with a higher risk of dementia: a nation-wide, population-based, case-control study. Int J Rheum Dis 21(2):373\u2013380. https:\/\/doi.org\/10.1111\/1756-185x.13246","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"5372_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/acr.23243","volume":"70","author":"T Meade","year":"2018","unstructured":"Meade T, Manolios N, Cumming SR, Conaghan PG, Katz P (2018) Cognitive impairment in rheumatoid arthritis: a systematic review. Arthritis Care Res 70(1):39\u201352. https:\/\/doi.org\/10.1002\/acr.23243","journal-title":"Arthritis Care Res"},{"key":"5372_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jocn.2019.08.027","volume":"69","author":"BK Vitturi","year":"2019","unstructured":"Vitturi BK, Nascimento BAC, Alves BR, de Campos FSC, Torigoe DY (2019) Cognitive impairment in patients with rheumatoid arthritis. J Clin Neurosci 69:81\u201387. https:\/\/doi.org\/10.1016\/j.jocn.2019.08.027","journal-title":"J Clin Neurosci"},{"issue":"1","key":"5372_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/0028-3886.173623","volume":"64","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Wijarnpreecha K, Thongprayoon C (2016) Rheumatoid arthritis and the risk of dementia: a systematic review and meta-analysis. Neurol India 64(1):56\u201361. https:\/\/doi.org\/10.4103\/0028-3886.173623","journal-title":"Neurol India"},{"key":"5372_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-2012-111736","volume":"31","author":"K Wallin","year":"2012","unstructured":"Wallin K, Solomon A, K\u00e5reholt I, Tuomilehto J, Soininen H, Kivipelto M (2012) Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J Alzheimers Dis 31:669\u2013676. https:\/\/doi.org\/10.3233\/JAD-2012-111736","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"5372_CR39","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1212\/wnl.58.8.1214","volume":"58","author":"RL Brey","year":"2002","unstructured":"Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL et al (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 58(8):1214\u20131220. https:\/\/doi.org\/10.1212\/wnl.58.8.1214","journal-title":"Neurology."},{"issue":"11","key":"5372_CR40","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/art.24189","volume":"59","author":"E Kozora","year":"2008","unstructured":"Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L (2008) Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum 59(11):1639\u20131646. https:\/\/doi.org\/10.1002\/art.24189","journal-title":"Arthritis Rheum"},{"key":"5372_CR41","doi-asserted-by":"publisher","unstructured":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. (1999) Arthritis & Rheumatism. 42(4):599\u2013608. https:\/\/doi.org\/10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F"},{"issue":"5","key":"5372_CR42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/art.20692","volume":"51","author":"E Kozora","year":"2004","unstructured":"Kozora E, Ellison MC, West S (2004) Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Care Res 51(5):810\u2013818. https:\/\/doi.org\/10.1002\/art.20692","journal-title":"Arthritis Care Res"},{"issue":"2","key":"5372_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.semarthrit.02.007","volume":"48","author":"HA Rayes","year":"2018","unstructured":"Rayes HA, Tani C, Kwan A, Marzouk S, Colosimo K, Medina-Rosas J, Mustafa A, Su J, Lambiris P, Mosca M, Touma Z (2018) What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis. Semin Arthritis Rheum 48(2):240\u2013255. https:\/\/doi.org\/10.1016\/j.semarthrit.02.007","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"5372_CR44","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1177\/0961203317751859","volume":"27","author":"B Leslie","year":"2018","unstructured":"Leslie B, Crowe SF (2018) Cognitive functioning in systemic lupus erythematosus: a meta-analysis. Lupus. 27(6):920\u2013929. https:\/\/doi.org\/10.1177\/0961203317751859","journal-title":"Lupus."},{"issue":"7","key":"5372_CR45","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1177\/0961203318763533","volume":"27","author":"B Cannerfelt","year":"2018","unstructured":"Cannerfelt B, Nystedt J, Jonsen A, Latt J, van Westen D, Lilja A et al (2018) White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus. Lupus. 27(7):1140\u20131149. https:\/\/doi.org\/10.1177\/0961203318763533","journal-title":"Lupus."},{"issue":"3","key":"5372_CR46","doi-asserted-by":"publisher","first-page":"e33824-e","DOI":"10.1371\/journal.pone.0033824","volume":"7","author":"F Conti","year":"2012","unstructured":"Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F et al (2012) Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One 7(3):e33824-e. https:\/\/doi.org\/10.1371\/journal.pone.0033824","journal-title":"PLoS One"},{"key":"5372_CR47","doi-asserted-by":"crossref","unstructured":"J S\u00e4ve-S\u00f6derbergh, B E Malmvall, R Andersson, B A Bengtsson (1986) Giant cell arteritis as a cause of death. Report of nine cases. (0098\u20137484 (Print))","DOI":"10.1001\/jama.1986.03370040067025"},{"issue":"5","key":"5372_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","volume":"27","author":"IM Wilkinson","year":"1972","unstructured":"Wilkinson IM, Russell RW (1972) Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 27(5):378\u2013391. https:\/\/doi.org\/10.1001\/archneur.1972.00490170010003","journal-title":"Arch Neurol"},{"issue":"5","key":"5372_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","volume":"84","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84(5):269\u2013276. https:\/\/doi.org\/10.1097\/01.md.0000180042.42156.d1","journal-title":"Medicine (Baltimore)"},{"key":"5372_CR50","doi-asserted-by":"publisher","unstructured":"Alsolaimani RS, Bhavsar SV, Khalidi NA, Pagnoux C, Mandzia JL, Tay K et al (2016) Severe intracranial involvement in giant cell arteritis: 5 cases and literature review. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.150143","DOI":"10.3899\/jrheum.150143"},{"issue":"28","key":"5372_CR51","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/md.0000000000000265","volume":"93","author":"D Lariviere","year":"2014","unstructured":"Lariviere D, Sacre K, Klein I, Hyafil F, Choudat L, Chauveheid MP et al (2014) Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study. Medicine (Baltimore) 93(28):e265. https:\/\/doi.org\/10.1097\/md.0000000000000265","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 2","key":"5372_CR52","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/annrheumdis-2019-eular.4695","volume":"78","author":"MD Carlo","year":"2019","unstructured":"Carlo MD, Becciolini A, Incorvaia A, Beci G, Biggioggero M, Favalli EG et al (2019) SAT0375 Mild cognitive impairment in psoriatic arthritis: prevalence and associated factors. Ann Rheum Dis 78(Suppl 2):1271. https:\/\/doi.org\/10.1136\/annrheumdis-2019-eular.4695","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5372_CR53","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5114\/ada.2017.67074","volume":"34","author":"L Marek-J\u00f3zefowicz","year":"2017","unstructured":"Marek-J\u00f3zefowicz L, Jaracz M, Placek W, Czajkowski R, Borkowska A (2017) Cognitive impairment in patients with severe psoriasis. Postepy Dermatol Alergol 34(2):120\u2013125. https:\/\/doi.org\/10.5114\/ada.2017.67074","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"5372_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000357220","volume":"228","author":"P Gisondi","year":"2014","unstructured":"Gisondi P, Sala F, Alessandrini F, Avesani V, Zoccatelli G, Beltramello A, Moretto G, Gambina G, Girolomoni G (2014) Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology. 228(1):78\u201385. https:\/\/doi.org\/10.1159\/000357220","journal-title":"Dermatology."},{"issue":"3","key":"5372_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 163(3):586\u2013592. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09941.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"5372_CR56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2133.2005.06950.x","volume":"154","author":"E Campalani","year":"2006","unstructured":"Campalani E, Allen MH, Fairhurst D, Young HS, Mendonca CO, Burden AD, Griffiths CEM, Crook MA, Barker JNWN, Smith CH (2006) Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol 154(2):345\u2013352. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06950.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"5372_CR57","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley RW, Rall SC (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1(1):507\u2013537. https:\/\/doi.org\/10.1146\/annurev.genom.1.1.507","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"5372_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1326-6-69","volume":"6","author":"H Jiang","year":"2011","unstructured":"Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, Shen Y (2011) Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease. Mol Neurodegener 6:69. https:\/\/doi.org\/10.1186\/1750-1326-6-69","journal-title":"Mol Neurodegener"},{"issue":"9","key":"5372_CR59","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/11310810-000000000-00000","volume":"23","author":"E Tobinick","year":"2009","unstructured":"Tobinick E (2009) Tumour necrosis factor modulation for treatment of Alzheimer\u2019s disease: rationale and current evidence. CNS Drugs 23(9):713\u2013725. https:\/\/doi.org\/10.2165\/11310810-000000000-00000","journal-title":"CNS Drugs"},{"issue":"2","key":"5372_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/cjn.2020.14","volume":"47","author":"BK Vitturi","year":"2020","unstructured":"Vitturi BK, Suriano ES, Pereira de Sousa AB, Torigoe DY (2020) Cognitive impairment in patients with ankylosing spondylitis. Can J Neurol Sci 47(2):219\u2013225. https:\/\/doi.org\/10.1017\/cjn.2020.14","journal-title":"Can J Neurol Sci"},{"issue":"6","key":"5372_CR61","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00296-010-1381-x","volume":"31","author":"O Baysal","year":"2011","unstructured":"Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K et al (2011) Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 31(6):795\u2013800. https:\/\/doi.org\/10.1007\/s00296-010-1381-x","journal-title":"Rheumatol Int"},{"issue":"10","key":"5372_CR62","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/rheumatology\/kel115","volume":"45","author":"J Martindale","year":"2006","unstructured":"Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA (2006) Disease and psychological status in ankylosing spondylitis. Rheumatology (Oxford) 45(10):1288\u20131293. https:\/\/doi.org\/10.1093\/rheumatology\/kel115","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5372_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210335","volume":"14","author":"HD Jang","year":"2019","unstructured":"Jang HD, Park JS, Kim DW, Han K, Shin BJ, Lee JC, Choi SW, Suh SW, Yang JH, Park SY, Cho WJ, Hong JY (2019) Relationship between dementia and ankylosing spondylitis: a nationwide, population-based, retrospective longitudinal cohort study. PLoS One 14(1):e0210335. https:\/\/doi.org\/10.1371\/journal.pone.0210335","journal-title":"PLoS One"},{"issue":"6","key":"5372_CR64","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/jgs.13517","volume":"63","author":"L Dautzenberg","year":"2015","unstructured":"Dautzenberg L, Jessurum N, Dautzenberg PLJ, Keijsers CJPW (2015) Reversible methotrexate-induced dementia: a case report. J Am Geriatr Soc 63(6):1273\u20131274. https:\/\/doi.org\/10.1111\/jgs.13517","journal-title":"J Am Geriatr Soc"},{"key":"5372_CR65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.taap.2017.09.014","volume":"334","author":"M-H Chou","year":"2017","unstructured":"Chou M-H, Wang J-Y, Lin C-L, Chung W-S (2017) DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: a propensity score-matched case\u2013control study. Toxicol Appl Pharmacol 334:217\u2013222. https:\/\/doi.org\/10.1016\/j.taap.2017.09.014","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"5372_CR66","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.trci.2017.10.002","volume":"3","author":"A Judge","year":"2017","unstructured":"Judge A, Garriga C, Arden NK, Lovestone S, Prieto-Alhambra D, Cooper C, Edwards CJ (2017) Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients. Alzheimers Dement (N Y) 3(4):612\u2013621. https:\/\/doi.org\/10.1016\/j.trci.2017.10.002","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"5372_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13195-020-00606-5","volume":"12","author":"D Newby","year":"2020","unstructured":"Newby D, Prieto-Alhambra D, Duarte-Salles T, Ansell D, Pedersen L, van der Lei J, Mosseveld M, Rijnbeek P, James G, Alexander M, Egger P, Podhorna J, Stewart R, Perera G, Avillach P, Grosdidier S, Lovestone S, Nevado-Holgado AJ (2020) Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study. Alzheimers Res Ther 12(1):38. https:\/\/doi.org\/10.1186\/s13195-020-00606-5","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"5372_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/annrheumdis-2018-214016","volume":"78","author":"L Fardet","year":"2019","unstructured":"Fardet L, Nazareth I, Petersen I (2019) Chronic hydroxychloroquine\/chloroquine exposure for connective tissue diseases and risk of Alzheimer\u2019s disease: a population-based cohort study. Ann Rheum Dis 78(2):279\u201327282. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214016","journal-title":"Ann Rheum Dis"},{"issue":"9280","key":"5372_CR69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/s0140-6736(01)05623-9","volume":"358","author":"WA Van Gool","year":"2001","unstructured":"Van Gool WA, Weinstein HC, Scheltens P, Walstra GJ (2001) Effect of hydroxychloroquine on progression of dementia in early Alzheimer\u2019s disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet. 358(9280):455\u2013460. https:\/\/doi.org\/10.1016\/s0140-6736(01)05623-9","journal-title":"Lancet."},{"issue":"11","key":"5372_CR70","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s40263-016-0374-z","volume":"30","author":"RC Chou","year":"2016","unstructured":"Chou RC, Kane M, Ghimire S, Gautam S, Gui J (2016) Treatment for rheumatoid arthritis and risk of Alzheimer's disease: a nested case-control analysis. CNS Drugs 30(11):1111\u20131120. https:\/\/doi.org\/10.1007\/s40263-016-0374-z","journal-title":"CNS Drugs"},{"issue":"3","key":"5372_CR71","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/gps.4793","volume":"33","author":"B McGuinness","year":"2018","unstructured":"McGuinness B, Holmes C, Mirakhur A, Kearsley-Fleet L, Vieira R, Watson K, BSRBR-RA Contributors Group, BSRBR-RA Control Centre Consortium, Hyrich K (2018) The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR-RA. Int J Geriatr Psychiatry 33(3):556\u2013558. https:\/\/doi.org\/10.1002\/gps.4793","journal-title":"Int J Geriatr Psychiatry"},{"key":"5372_CR72","doi-asserted-by":"publisher","unstructured":"Zhou M, Xu R, Kaelber DC, Gurney ME (2020) Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.\u00a0PLoS One 15(3):e0229819. https:\/\/doi.org\/10.1371\/journal.pone.0229819","DOI":"10.1371\/journal.pone.0229819"},{"key":"5372_CR73","unstructured":"McGuinness B (2018) Understanding whether drugs for rheumatoid arthritis can reduce the risk of Alzheimer\u2019s disease. Alzheimer's Society. https:\/\/www.alzheimers.org.uk\/research\/our-research\/research-projects\/understanding-whether-drugs-rheumatoid-arthritis-can-reduce-risk-alzheimersdisease"},{"issue":"3","key":"5372_CR74","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bja.2017.11.096","volume":"120","author":"J Hu","year":"2018","unstructured":"Hu J, Feng X, Valdearcos M, Lutrin D, Uchida Y, Koliwad SK, Maze M (2018) Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice. Br J Anaesth 120(3):537\u2013545. https:\/\/doi.org\/10.1016\/j.bja.2017.11.096","journal-title":"Br J Anaesth"},{"issue":"1\u20132","key":"5372_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11010-016-2762-6","volume":"420","author":"HK Elcioglu","year":"2016","unstructured":"Elcioglu HK, Aslan E, Ahmad S, Alan S, Salva E, Elcioglu OH et al (2016) Tocilizumab's effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer's model. Mol Cell Biochem 420(1\u20132):21\u201328. https:\/\/doi.org\/10.1007\/s11010-016-2762-6","journal-title":"Mol Cell Biochem"},{"issue":"15","key":"5372_CR76","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2169\/internalmedicine.48.1926","volume":"48","author":"K Kobayashi","year":"2009","unstructured":"Kobayashi K, Okamoto Y, Inoue H, Usui T, Ihara M, Kawamata J, Miki Y, Mimori T, Tomimoto H, Takahashi R (2009) Leukoencephalopathy with cognitive impairment following tocilizumab for the treatment of rheumatoid arthritis (RA). Intern Med 48(15):1307\u20131309. https:\/\/doi.org\/10.2169\/internalmedicine.48.1926","journal-title":"Intern Med"},{"issue":"8","key":"5372_CR77","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2169\/internalmedicine.53.0615","volume":"53","author":"Y Yamaguchi","year":"2014","unstructured":"Yamaguchi Y, Furukawa K, Yamamoto T, Takahashi Y, Tanaka K, Takahashi M (2014) Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy. Intern Med 53(8):879\u2013882. https:\/\/doi.org\/10.2169\/internalmedicine.53.0615","journal-title":"Intern Med"},{"key":"5372_CR78","doi-asserted-by":"publisher","first-page":"681678","DOI":"10.1155\/2014\/681678","volume":"2014","author":"S Bugatti","year":"2014","unstructured":"Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A (2014) B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. Biomed Res Int 2014:681678\u2013681614. https:\/\/doi.org\/10.1155\/2014\/681678","journal-title":"Biomed Res Int"},{"issue":"5 Suppl 46","key":"5372_CR79","first-page":"S4","volume":"25","author":"AP Cope","year":"2007","unstructured":"Cope AP, Schulze-Koops H, Aringer M (2007) The central role of T cells in rheumatoid arthritis. Clin Exp Rheumatol 25(5 Suppl 46):S4\u2013S11","journal-title":"Clin Exp Rheumatol"},{"key":"5372_CR80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fnins.2014.00357","volume":"8","author":"NR Fuggle","year":"2014","unstructured":"Fuggle NR, Howe FA, Allen RL, Sofat N (2014) New insights into the impact of neuro-inflammation in rheumatoid arthritis. Front Neurosci 8:357. https:\/\/doi.org\/10.3389\/fnins.2014.00357","journal-title":"Front Neurosci"},{"key":"5372_CR81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2017.11.015","volume":"315","author":"C Chang","year":"2018","unstructured":"Chang C, Zhao Y, Song G, She K (2018) Resveratrol protects hippocampal neurons against cerebral ischemia-reperfusion injury via modulating JAK\/ERK\/STAT signaling pathway in rats. J Neuroimmunol 315:9\u201314. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.11.015","journal-title":"J Neuroimmunol"},{"issue":"6","key":"5372_CR82","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1523\/jneurosci.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Ceyzeriat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, Vandesquille M, Aron-Badin R, Dhenain M, Deglon N, Hantraye P, Brouillet E, Bonvento G, Escartin C (2015) The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases. J Neurosci 35(6):2817\u20132829. https:\/\/doi.org\/10.1523\/jneurosci.3516-14.2015","journal-title":"J Neurosci"},{"key":"5372_CR83","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12891-016-1185-6","volume":"17","author":"S-K Cho","year":"2016","unstructured":"Cho S-K, Sung Y-K, Kim D, Won S, Choi C-B, Kim T-H et al (2016) Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis. BMC Musculoskelet Disord 17:333. https:\/\/doi.org\/10.1186\/s12891-016-1185-6","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"5372_CR84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-009-8142-1","volume":"38","author":"M Filippini","year":"2010","unstructured":"Filippini M, Bazzani C, Favalli EG, Marchesoni A, Atzeni F, Sarzi-Puttini P, Pallavicini FB, Caporali R, Gorla R (2010) Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study. Clin Rev Allergy Immunol 38(2):90\u201396. https:\/\/doi.org\/10.1007\/s12016-009-8142-1","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"5372_CR85","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.cgh.2018.12.032","volume":"17","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, Ananthakrishnan AN (2019) Safety of biologic therapy in older patients with immune-mediated diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 17(9):1736\u201343.e4. https:\/\/doi.org\/10.1016\/j.cgh.2018.12.032","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05372-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05372-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T23:17:42Z","timestamp":1630279062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05372-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,30]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5372"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05372-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,30]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}